Northwestern Mutual Wealth Management’s Cidara Therapeutics CDTX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$221	–	4177
2025 Q4	$221	Buy	+1	New	+$162	﹤0.01%	3797
2024 Q3	–	Sell	-14	Closed	-$167	–	3618
2024 Q2	$167	Buy	+14	New	+$192	﹤0.01%	3370

Northwestern Mutual Wealth Management's CDTX Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1 share — an estimated $221 sold.

Northwestern Mutual Wealth Management first reported a position in CDTX in Q2 2024 and held it in 2 quarters. The position peaked at $221 in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Northwestern Mutual Wealth Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 1 Cidara Therapeutics share in Q1 2026, an estimated $221.
Northwestern Mutual Wealth Management first reported a position in Cidara Therapeutics in Q2 2024 and held it in 2 quarters.
Northwestern Mutual Wealth Management's Cidara Therapeutics position peaked at $221 in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.